Clinical Trial Update: A Study of Ninlaro in Real World Clinical Practice in China

View source ↗

Summary

A completed real-world study evaluating Ninlaro (ixazomib) in Chinese clinical practice for multiple myeloma. The study analyzes how the drug is used in routine…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma
• Plasma Cell Neoplasms

Drugs mentioned

• NINLARO (ixazomib)

Snippet

Sponsor: Takeda | Conditions: Multiple Myeloma, Neoplasms, Plasma Cell | Status: COMPLETED